Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

Don’t Try to Catch the Falling Knife With Marin Software

By Thomas Niel, InvestorPlace Contributor

The circumstances that shot MRIN stock to the moon a month ago aren't likely to repeat anytime soon. Expect share prices to fall even more.

No Need to Hop on the Exela Bandwagon

By Thomas Niel, InvestorPlace Contributor

So, with the merits of buying it as a short-squeeze or as a turnaround play debatable, what's the best move with XELA stock? Ahead of it pulling back further, consider it a stock to avoid.

Tilray Stock Is Worth Buying and Holding If You Have a Little Patience

By Thomas Niel, InvestorPlace Contributor

It may remain volatile for now. But in the long-run, TLRY stock could climb to levels far above where it trades today (around $17 per share).

Throw in The Towel, Ocugen Stock is Not Coming Back

By Thomas Niel, InvestorPlace Contributor

Barring the slim chance it gets EUA in Canada, which admittedly could result in an outsized move higher? Expect OCGN stock to continue trending lower, eventually falling back to around 70 cents per share.

Cleveland-Cliffs Stock Is a Buy Even If the Infrastructure Bill Fizzles

By Thomas Niel, InvestorPlace Contributor

So, with the infrastructure bill catalyst, along with a catalyst that could play out, whether said bill passes or not, what's the verdict on CLF stock? With room to add to its epic gains in the past twelve months, consider it a buy at today's prices.

Clover Stock Is Really Unlikely To Get Squeezed Again

By Thomas Niel, InvestorPlace Contributor

There's a reason why CLOV stock has been shorted heavily. With trading trends no longer your friend, there's little reason to dive in today.

Upcoming Earnings Could Bring Back Positive Sentiment for Skillz

By Thomas Niel, InvestorPlace Contributor

After its recent sell-off, next week's quarterly numbers could be enough to put SKLZ stock back on an upwards trajectory.

Expect More Underwhelming Performance for SoFi Shares

By Thomas Niel, InvestorPlace Contributor

So, with more negatives than positives, SOFI stock is likely to either going to trade sideways in the short-term. Or worse, head down to lower prices. With this in mind, even investors who believe it's a long-term winner shouldn't hastily dive into it.

Don’t Bet on DiDi Global Stock Yet

By Thomas Niel, InvestorPlace Contributor

As China's regulatory crackdown on Didi continues, the verdict on DIDI stock is crystal clear: stay away for now.

Coupang Stock is Reasonably Priced, But Patience is Key

By Thomas Niel, InvestorPlace Contributor

Another growth stock correction, caused by rising worries about inflation, interest rates, and slowing growth, could push CPNG stock back down near its lows. Given this factor, "wait and see" remains the best move for now.

Load More